Corcept Therapeutics
CORT
#2251
Rank
C$12.13 B
Marketcap
C$113.02
Share price
-2.25%
Change (1 day)
15.84%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of March 2026 : C$13.62 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is C$13.62 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2026)

Total debt by year

Year Total debt Change
2025-12-31C$8.36 M-15.97%
2024-12-31C$9.95 M4869.58%
2023-12-31C$0.2 M-87.09%
2022-12-31C$1.55 M131.37%
2021-12-31C$0.67 M-79.39%
2020-12-31C$3.25 M-28.04%
2019-12-31C$4.52 M
2018-12-31N/A
2016-12-31C$19.7 M-5.07%
2015-12-31C$20.75 M89.82%
2014-12-31C$10.93 M78.89%
2013-12-31C$6.11 M131.99%
2012-12-31C$2.63 M
2010-12-31N/A-100%
2009-12-31C$0 M-67.55%
2008-12-31C$0.01 M-32.75%
2007-12-31C$0.02 M-40.84%
2006-12-31C$0.04 M-22.22%
2005-12-31C$0.06 M
2003-12-31C$0.67 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
C$77.76 B 570,482.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$66.46 B 487,582.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$90.13 B 661,205.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$61.33 B 449,936.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$69.46 B 509,571.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$65.66 B 481,668.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$0.46 B 3,334.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.43 B 3,083.51%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.03 B 14,838.26%๐Ÿ‡บ๐Ÿ‡ธ USA